Literature DB >> 18523146

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

Sumithira Vasu1, Susan F Leitman, John F Tisdale, Matthew M Hsieh, Richard W Childs, A John Barrett, Daniel H Fowler, Michael R Bishop, Elizabeth M Kang, Harry L Malech, Cynthia E Dunbar, Hanh M Khuu, Robert Wesley, Yu Y Yau, Charles D Bolan.   

Abstract

A reliable estimate of peripheral blood stem cell (PBSC) mobilization response to granulocyte colony-stimulating factor (G-CSF) may identify donors at risk for poor mobilization and help optimize transplantation approaches. We studied 639 allogeneic PBSC collections performed in 412 white, 75 black, 116 Hispanic, and 36 Asian/Pacific adult donors who were prescribed G-CSF dosed at either 10 or 16 microg/kg per day for 5 days followed by large-volume leukapheresis (LVL). Additional LVL (mean, 11 L) to collect lymphocytes for donor lymphocyte infusion (DLI) and other therapies was performed before G-CSF administration in 299 of these donors. Day 5 preapheresis blood CD34(+) cell counts after mobilization were significantly lower in whites compared with blacks, Hispanics, and Asian/Pacific donors (79 vs 104, 94, and 101 cells/microL, P < .001). In addition, donors who underwent lymphapheresis before mobilization had higher CD34(+) cell counts than donors who did not (94 vs 79 cells/microL, P < .001). In multivariate analysis, higher post-G-CSF CD34(+) cell counts were most strongly associated with the total amount of G-CSF received, followed by the pre-G-CSF platelet count, pre-G-CSF mononuclear count, and performance of prior LVL for DLI collection. Age, white ethnicity, and female gender were associated with significantly lower post-G-CSF CD34(+) cell counts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523146      PMCID: PMC2518908          DOI: 10.1182/blood-2008-03-143677

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.

Authors:  A Gratwohl; H Baldomero; O Schmid; B Horisberger; M Bargetzi; A Urbano-Ispizua
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

2.  Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation.

Authors:  C Arbona; F Prosper; I Benet; F Mena; C Solano; J Garcia-Conde
Journal:  Bone Marrow Transplant       Date:  1998-07       Impact factor: 5.483

3.  Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy.

Authors:  G Miflin; C Charley; C Stainer; S Anderson; A Hunter; N Russell
Journal:  Br J Haematol       Date:  1996-11       Impact factor: 6.998

4.  The influence of automated plateletpheresis on systemic levels of hematopoietic growth factors.

Authors:  V Weisbach; H Friedlein; A Glaser; J Zingsem; R Zimmermann; R Eckstein
Journal:  Transfusion       Date:  1999-08       Impact factor: 3.157

5.  Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.

Authors:  P Anderlini; D Przepiorka; C Seong; T L Smith; Y O Huh; J Lauppe; R Champlin; M Körbling
Journal:  Transfusion       Date:  1997-05       Impact factor: 3.157

6.  Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.

Authors:  D Przepiorka; T L Smith; J Folloder; I Khouri; N T Ueno; R Mehra; M Körbling; Y O Huh; S Giralt; J Gajewski; M Donato; K Cleary; D Claxton; I Braunschweig; K van Besien; B S Andersson; P Anderlini; R Champlin
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

7.  Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.

Authors:  H Suzuya; T Watanabe; R Nakagawa; H Watanabe; Y Okamoto; T Onishi; T Abe; Y Kawano; S Kagami; Y Takaue
Journal:  Vox Sang       Date:  2005-11       Impact factor: 2.144

Review 8.  PBSC mobilization.

Authors:  Kunihiko Takeyama; Hitoshi Ohto
Journal:  Transfus Apher Sci       Date:  2004-12       Impact factor: 1.764

9.  Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks.

Authors:  Karen K Ballen; Joanne Kurtzberg; Thomas A Lane; Bruce R Lindgren; John P Miller; Denis Nagan; Bruce Newman; Neil Rupp; N Rebecca Haley
Journal:  Biol Blood Marrow Transplant       Date:  2004-04       Impact factor: 5.742

10.  Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis.

Authors:  M Dettke; M Hlousek; M Kurz; G Leitner; K Rosskopf; G Stiegler; P Stohlawetz; N Worel; P Höcker; S Panzer
Journal:  Transfusion       Date:  1998-05       Impact factor: 3.157

View more
  34 in total

1.  Significant mobilization of both conventional and regulatory T cells with AMD3100.

Authors:  Leslie S Kean; Sharon Sen; Olusegun Onabajo; Karnail Singh; Jennifer Robertson; Linda Stempora; Aylin C Bonifacino; Mark E Metzger; Daniel E L Promislow; Joseph J Mattapallil; Robert E Donahue
Journal:  Blood       Date:  2011-10-11       Impact factor: 22.113

2.  Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

Authors:  Robert E Donahue; Ping Jin; Aylin C Bonifacino; Mark E Metzger; Jiaqiang Ren; Ena Wang; David F Stroncek
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

3.  Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.

Authors:  Sandhya R Panch; Yu Ying Yau; Courtney D Fitzhugh; Matthew M Hsieh; John F Tisdale; Susan F Leitman
Journal:  Transfusion       Date:  2016-05       Impact factor: 3.157

Review 4.  G-CSF in Healthy Allogeneic Stem Cell Donors.

Authors:  Kristina Hölig
Journal:  Transfus Med Hemother       Date:  2013-07-22       Impact factor: 3.747

5.  Efficacy and side effects of granulocyte collection in healthy donors.

Authors:  Franziska Brockmann; Michael Kramer; Martin Bornhäuser; Gerhard Ehninger; Kristina Hölig
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

6.  A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers.

Authors:  Steven J Lemery; Matthew M Hsieh; Aleah Smith; Sheila Rao; Hanh M Khuu; Donohue Theresa; Jennifer M Viano; Lisa Cook; Rose Goodwin; Carol Boss; Gary Calandra; Nancy Geller; John Tisdale; Richard Childs
Journal:  Br J Haematol       Date:  2011-02-24       Impact factor: 6.998

7.  Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?

Authors:  Matthew M Hsieh; John F Tisdale; Griffin P Rodgers; Neal S Young; Edward L Trimble; Richard F Little
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

8.  The impact of improved JACIE standards on the care of related BM and PBSC donors.

Authors:  C Anthias; M E Ethell; M N Potter; A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

9.  Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors.

Authors:  Kenneth S Cohen; Susan Cheng; Martin G Larson; L Adrienne Cupples; Elizabeth L McCabe; Ying A Wang; Julius S Ngwa; Roderick P Martin; Rachael J Klein; Basma Hashmi; Yin Ge; Christopher J O'Donnell; Ramachandran S Vasan; Stanley Y Shaw; Thomas J Wang
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

10.  Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.

Authors:  C Zhang; X-H Chen; X Zhang; L Gao; L Gao; P-Y Kong; X-G Peng; A-H Sun; Y Gong; D-F Zeng; Q-Y Wang
Journal:  Transfus Med       Date:  2010-02-01       Impact factor: 2.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.